Logo image of MILE

METROMILE INC (MILE) Stock Fundamental Analysis

USA - NASDAQ:MILE - US5916971071 - Common Stock

1.05 USD
+0.07 (+7.67%)
Last: 7/27/2022, 8:12:46 PM
1.02 USD
-0.03 (-2.86%)
After Hours: 7/27/2022, 8:12:46 PM
Fundamental Rating

2

Overall MILE gets a fundamental rating of 2 out of 10. We evaluated MILE against 146 industry peers in the Insurance industry. The financial health of MILE is average, but there are quite some concerns on its profitability. MILE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MILE had negative earnings in the past year.
MILE Yearly Net Income VS EBIT VS OCF VS FCFMILE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -50M -100M -150M -200M

1.2 Ratios

Industry RankSector Rank
ROA -49.8%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MILE Yearly ROA, ROE, ROICMILE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 -20 -40 -60 -80 -100

1.3 Margins

MILE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) -135.85%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MILE Yearly Profit, Operating, Gross MarginsMILE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

MILE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MILE has been increased compared to 1 year ago.
MILE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MILE Yearly Shares OutstandingMILE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 20M 40M 60M 80M 100M
MILE Yearly Total Debt VS Total AssetsMILE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

MILE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.55%
MILE Yearly LT Debt VS Equity VS FCFMILE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M -100M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MILE Yearly Current Assets VS Current LiabilitesMILE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 100K 200K 300K 400K

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MILE have decreased strongly by -9949.68% in the last year.
EPS 1Y (TTM)-9949.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.81%

3.2 Future

MILE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.03% yearly.
MILE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.64% yearly.
EPS Next Y62.43%
EPS Next 2Y32.18%
EPS Next 3Y18.29%
EPS Next 5Y11.03%
Revenue Next Year21.19%
Revenue Next 2Y30.12%
Revenue Next 3Y29.37%
Revenue Next 5Y29.64%

3.3 Evolution

MILE Yearly Revenue VS EstimatesMILE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 50M 100M 150M 200M
MILE Yearly EPS VS EstimatesMILE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MILE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MILE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MILE Price Earnings VS Forward Price EarningsMILE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.35
MILE Per share dataMILE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as MILE's earnings are expected to grow with 18.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.18%
EPS Next 3Y18.29%

More info and screens

0

5. Dividend

5.1 Amount

MILE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

METROMILE INC

NASDAQ:MILE (7/27/2022, 8:12:46 PM)

After market: 1.02 -0.03 (-2.86%)

1.05

+0.07 (+7.67%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-10 2022-05-10/amc
Earnings (Next)08-08 2022-08-08
Inst Owners0%
Inst Owner Change0%
Ins Owners4.44%
Ins Owner Change0%
Market Cap136.94M
Analysts45.71
Price Target4.08 (288.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB N/A
EV/EBITDA -0.35
EPS(TTM)-1.14
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.83
BVpS1.21
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -135.85%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9949.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.29%
EPS Next Y62.43%
EPS Next 2Y32.18%
EPS Next 3Y18.29%
EPS Next 5Y11.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.81%
Revenue Next Year21.19%
Revenue Next 2Y30.12%
Revenue Next 3Y29.37%
Revenue Next 5Y29.64%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A